MY129714A - Preparations for topical administration of substances having antiandrogenic activity - Google Patents
Preparations for topical administration of substances having antiandrogenic activityInfo
- Publication number
- MY129714A MY129714A MYPI20031577A MYPI20031577A MY129714A MY 129714 A MY129714 A MY 129714A MY PI20031577 A MYPI20031577 A MY PI20031577A MY PI20031577 A MYPI20031577 A MY PI20031577A MY 129714 A MY129714 A MY 129714A
- Authority
- MY
- Malaysia
- Prior art keywords
- preparations
- substances
- topical administration
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A PREPARATION COMPRISING AT LEAST ONE FORM OF LIPID NANOPARTICLES OR A NANOEMULSION COMPRISING AT LEAST ONE COMPOUND OF THE FORMULA 1:AND/OR ONE STEREOISOMERIC FORM OF THE COMPOUND OF THE FORMULA 1 AND/OR ONE PHYSIOLOGICALLY TOLERATED SALT OF THE COMPOUND OF THE FORMULA 1, IN WHICH R1 IS -(C5-C17)-ALKYL OR -(C5-C17)-ALKENYL, IS SUITABLE FOR THE TREATMENT OF ANDROGENIC ALOPECIA, OF HIRSUTISM, THAT IS TO SAY TO PREVENT UNWANTED HAIR GROWTH, AND FOR THE TREATMENT OF SEBORRHEA AND ANCE AND CAN FURTHERMORE BE EMPLOYED IN COSMETICS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10218963A DE10218963A1 (en) | 2002-04-27 | 2002-04-27 | Preparations for the topical application of antiandrogen active substances |
Publications (1)
Publication Number | Publication Date |
---|---|
MY129714A true MY129714A (en) | 2007-04-30 |
Family
ID=29264882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20031577A MY129714A (en) | 2002-04-27 | 2003-04-25 | Preparations for topical administration of substances having antiandrogenic activity |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1501806B1 (en) |
JP (1) | JP4633459B2 (en) |
AR (1) | AR039662A1 (en) |
AT (1) | ATE321756T1 (en) |
AU (1) | AU2003229658B2 (en) |
BR (1) | BRPI0309579B8 (en) |
CA (1) | CA2483786C (en) |
DE (2) | DE10218963A1 (en) |
DK (1) | DK1501806T3 (en) |
ES (1) | ES2256735T3 (en) |
IL (1) | IL164814A0 (en) |
MX (1) | MXPA04009571A (en) |
MY (1) | MY129714A (en) |
PE (1) | PE20031044A1 (en) |
PT (1) | PT1501806E (en) |
TW (1) | TWI285637B (en) |
WO (1) | WO2003093243A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4664814B2 (en) | 2003-06-12 | 2011-04-06 | 中外製薬株式会社 | Imidazolidine derivatives |
ATE502298T1 (en) | 2003-12-19 | 2011-04-15 | Univ California | METHODS AND MATERIALS FOR ASSESSING PROSTATE CANCER THERAPIES |
CN100475781C (en) * | 2004-02-13 | 2009-04-08 | 沃尼尔·朗伯有限责任公司 | Androgen receptor modulators |
KR100783255B1 (en) | 2004-02-13 | 2007-12-06 | 워너-램버트 캄파니 엘엘씨 | Androgen receptor modulators |
NZ550102A (en) | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
JP2007532621A (en) | 2004-04-13 | 2007-11-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Androgen modulator |
BRPI0509980A (en) | 2004-04-22 | 2007-10-16 | Warner Lambert Co | androgen modulators |
JP4874965B2 (en) * | 2004-07-08 | 2012-02-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Androgen regulator |
JP2008511606A (en) * | 2004-08-31 | 2008-04-17 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Androgen regulator |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
LT2656841T (en) | 2006-03-27 | 2016-09-26 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
KR101456722B1 (en) | 2006-03-29 | 2014-10-31 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Diarylthiohydantoin compounds |
TW201716385A (en) | 2007-10-26 | 2017-05-16 | 加州大學董事會 | Diarylhydantoin compounds |
PL3124481T3 (en) | 2010-02-16 | 2018-08-31 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and uses thereof |
RU2503446C2 (en) * | 2012-02-07 | 2014-01-10 | Алексей Валентинович Одинцов | Hair growth product (versions) and methods of treating alopecia |
EA202190820A1 (en) | 2012-09-26 | 2021-10-29 | Арагон Фармасьютикалз, Инк. | ANTIANDROGENS FOR TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER |
PL222631B1 (en) * | 2012-11-14 | 2016-08-31 | Gdański Univ Medyczny | Pharmaceutical composition comprising Roxithromycin, method for manufacture and medical use of the composition and the medicinal product comprising a composition |
WO2014078929A1 (en) * | 2012-11-26 | 2014-05-30 | Universidade Federal De Minas Gerais - Ufmg | Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth |
JOP20200097A1 (en) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | Androgen receptor modulator and uses thereof |
CN103965112A (en) * | 2014-05-13 | 2014-08-06 | 上海孚一生物科技有限公司 | Compound with antiandrogen activity as well as preparation method and application of compound |
TWI726969B (en) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | Substituted thiohydantoin derivatives as androgen receptor antagonists |
JOP20200076A1 (en) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals Inc | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2693461B1 (en) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | New substituted phenylimidazolidines, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them. |
AU726572B2 (en) * | 1994-02-16 | 2000-11-09 | Aventis Pharma S.A. | Cosmetics or pharmaceutical compositions consisting of liposomes |
FR2716110B1 (en) * | 1994-02-16 | 1996-04-05 | Roussel Uclaf | Cosmetic or pharmaceutical compositions comprising liposomes. |
-
2002
- 2002-04-27 DE DE10218963A patent/DE10218963A1/en not_active Ceased
-
2003
- 2003-04-14 JP JP2004501382A patent/JP4633459B2/en not_active Expired - Lifetime
- 2003-04-14 DK DK03722464T patent/DK1501806T3/en active
- 2003-04-14 PT PT03722464T patent/PT1501806E/en unknown
- 2003-04-14 WO PCT/EP2003/003837 patent/WO2003093243A1/en active IP Right Grant
- 2003-04-14 MX MXPA04009571A patent/MXPA04009571A/en active IP Right Grant
- 2003-04-14 DE DE50302818T patent/DE50302818D1/en not_active Expired - Lifetime
- 2003-04-14 CA CA2483786A patent/CA2483786C/en not_active Expired - Lifetime
- 2003-04-14 BR BRPI0309579A patent/BRPI0309579B8/en not_active IP Right Cessation
- 2003-04-14 AU AU2003229658A patent/AU2003229658B2/en not_active Expired
- 2003-04-14 EP EP03722464A patent/EP1501806B1/en not_active Expired - Lifetime
- 2003-04-14 AT AT03722464T patent/ATE321756T1/en active
- 2003-04-14 ES ES03722464T patent/ES2256735T3/en not_active Expired - Lifetime
- 2003-04-15 PE PE2003000383A patent/PE20031044A1/en active IP Right Grant
- 2003-04-24 TW TW092109533A patent/TWI285637B/en not_active IP Right Cessation
- 2003-04-24 AR ARP030101423A patent/AR039662A1/en active IP Right Grant
- 2003-04-25 MY MYPI20031577A patent/MY129714A/en unknown
-
2004
- 2004-10-25 IL IL16481404A patent/IL164814A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200407312A (en) | 2004-05-16 |
WO2003093243A1 (en) | 2003-11-13 |
IL164814A0 (en) | 2005-12-18 |
PT1501806E (en) | 2006-06-30 |
MXPA04009571A (en) | 2005-01-11 |
AU2003229658A1 (en) | 2003-11-17 |
DE50302818D1 (en) | 2006-05-18 |
DK1501806T3 (en) | 2006-05-29 |
ATE321756T1 (en) | 2006-04-15 |
TWI285637B (en) | 2007-08-21 |
BRPI0309579B8 (en) | 2021-05-25 |
PE20031044A1 (en) | 2004-02-09 |
JP2005535584A (en) | 2005-11-24 |
EP1501806A1 (en) | 2005-02-02 |
AU2003229658B2 (en) | 2010-07-29 |
BR0309579A (en) | 2005-03-01 |
ES2256735T3 (en) | 2006-07-16 |
CA2483786C (en) | 2011-08-09 |
AR039662A1 (en) | 2005-03-02 |
CA2483786A1 (en) | 2003-11-13 |
JP4633459B2 (en) | 2011-02-16 |
BR0309579B1 (en) | 2014-10-07 |
EP1501806B1 (en) | 2006-03-29 |
DE10218963A1 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY129714A (en) | Preparations for topical administration of substances having antiandrogenic activity | |
PL1863430T3 (en) | Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum. | |
WO2005000266A3 (en) | Liposomal formulations comprising a combination of two or more active agents | |
KR20000076549A (en) | A hair lotion with improved properties in its hair protecting action and prevention of hair loss, and the reduction of external effects of androgenic alopecia and resulting hair loss | |
WO2007113851A3 (en) | Novel compositions for hair disorders and process of preparation thereof | |
JP2007514695A5 (en) | ||
HK1032351A1 (en) | Topical compositions for enhancing glutathione production. | |
IL111293A0 (en) | Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia | |
JP2004500353A5 (en) | ||
IL142598A0 (en) | Preparations for topical application of substances having antiandrogenic effect | |
AU2011100917A4 (en) | Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens | |
KR20110045341A (en) | Improvement composite of scalp and hair be contain yeast, gold, propolis, ginseng, purslane, clove, pleuropterus multiflorus | |
IL132625A (en) | Composition for inducing hair growth | |
ES2137125A1 (en) | Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt. | |
KR19990018331A (en) | Hair growth promoting composition | |
WO2005009456A3 (en) | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | |
KR930703252A (en) | Use of coucurbitin used in the manufacture of anti-allergic cosmetics or pharmaceutical, especially dermatological compositions, and methods of using the same | |
AR006605A1 (en) | AN ANTIMICROBIAL HAIR TREATMENT COMPOSITION AND A METHOD FOR CARRYING OUT THE PREPARATION OF THE SAME. | |
EP2786747A1 (en) | Promoting hair growth solution containing chlorine dioxide preparation method and use method thereof | |
KR101307304B1 (en) | Composition for treating hair or scalp to prevent hair loss and promote growing hair | |
KR20090059230A (en) | Cosmetic composition for anti-alopecia and trichogenousness | |
US20240016816A1 (en) | Combination therapy | |
KR20100111640A (en) | Manufacturing method of cosmetic composition for trichogenousness or anti-alopecia | |
JPH11302128A (en) | Cosmetic for scalp and hair | |
GR1003832B (en) | Use of mastic oil and natural mastic for medicinal and cosmetic preparations |